The Life Sciences Industry of Tomorrow: Healthy Canadians, Healthy Future
The Life Sciences Industry of Tomorrow:
Healthy Canadians, Healthy Future
Pamela C. Fralick
President, Innovative Medicines Canada
The life sciences are innovating at an unprecedented pace, is government policy keeping up or holding us back?
The Atlantic Institute for Market Studies, in collaboration with Innovative Medicines Canada, is proud to present The Life Sciences Industry of Tomorrow: Healthy Canadians, Healthy Future.
Whether it’s artificial intelligence or new gene therapies that can potentially cure cancer, we are at a pivotal moment in the evolution and adoption of new technologies that will fundamentally change how we live, work, and treat illness. Access to these breakthrough technologies is key to our future health and prosperity and Canadians at the cutting edge of many of these new discoveries expect no less.
But as Pamela Fralick, President of Innovative Medicines Canada explains, proposed policy changes to Canada’s patented drug pricing regime will have profound implications for Canadian healthcare and the life sciences for decades to come.
Panel discussion to follow with Q&A. Confirmed panelists include Benjamin Davis, President of the Atlantic Division of the MS Society of Canada, and Dr. Peter Vaughan, Chair of Canada Health Infoway. Further panelists and details to follow.